跳至主要内容
临床试验/ACTRN12615000993594
ACTRN12615000993594尚未招募未知

Impact of sleep disturbances, circadian rhythm, comorbidities and medication in subjects with chronic obstructive pulmonary disease (COPD).

A/Prof Gregory King0 个研究点目标入组 100 人开始时间: 2015年9月22日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 1.A cigarette smoking history of >10 pack years.
  • 2.Subjects will have a post-bronchodilator FEV1/FVC ratio of <0.70
  • 3.A post-bronchodilator FEV1 of <60% of predicted (COPD-X moderate and severe disease)
  • 4.Report symptoms of COPD (exertional breathlessness, cough, wheeze or sputum production) at least 4 days/week.

排除标准

  • 1.A past Dr diagnosis of asthma
  • 2.Any other cardiac or pulmonary disease that is likely to significantly influence lung function and symptoms, e.g. heart failure, cancer, pleural disease, dementia.
  • 3.An inability to provide written informed consent.
  • 4.COPD exacerbation within the last 8 weeks
  • 5.The presence of cor pulmonale
  • 6.Use of home oxygen

研究者

发起方
A/Prof Gregory King

相似试验